Sentence examples for management of rejection from inspiring English sources

The rejection of heart transplants can be minimized through careful donor-patient matching and through the identification and management of rejection risk factors in recipients.

Our results suggest the importance of preventing rejection, as well as close monitoring and appropriate and aggressive management of rejection when it occurs.

Advances in technology and tracer development open new possibilities in regard to diagnosis and management of renal rejection.

Therefore, although some problems such as the most effective vector to employ for humans remain unresolved, in the future our method may have useful applications not only for treatment of autoimmune diseases but also for management of transplant rejection and GVHD in humans.

Analyst Josh Lipman said: Management's rejection of CVC's 950p bid, has led us to consider that there could be considerably more upside to pricing changes than we had initially expected.

Following the management's rejection of the track, Stewart and Nash dealt it out to other record labels.

Under this new protocol, additional agents, such as antimetabolites, are reserved for the management of patients experiencing episodes of rejection or deemed to be at high risk of rejection, at the discretion of the treating transplant physician.

rATG has also contributed to uneventful postoperative courses following human hand allografting [ 194], and management of steroid-resistant atypical rejection following hand transplantation [ 195].

Thus, these results suggest that ASKP1240 is immunosuppressive but not prothromboembolic, and as such appears to be a promising therapeutic candidate for the management of solid organ transplant rejection and autoimmune diseases therapy.

In single lung transplant, the management of pulmonary graft dysfunction, acute rejection, surgical pulmonary contusion and acute respiratory distress syndrome can all be managed with ILV rather than emergency re-transplantation [ 59].

Identification of reliable molecular markers that allows accurate prediction of clinical outcomes before a rejection episode occurs may help better management of the patients at higher risk for rejection.